Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR1 | P21462 | 5/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | FPR2 | P25090 | 2/20 | 0.33 |
| ▸ | BRAF | P15056 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24704875 | 0.91 | TP53 (0.33) | FPR1MAPTSMN1; SMN2NPSR1TP53 | |
| SCHEMBL24705049 | 0.89 | FAAH (0.31) | MAPTSMN1; SMN2TP53FAAHMEN1 | |
| SCHEMBL24705375 | 0.82 | USP2 (0.41) | MAPTSMN1; SMN2NPSR1TP53BRAF | |
| SCHEMBL24705137 | 0.78 | MAPT (0.36) | FPR1MAPTNPSR1BRAFMEN1 | |
| SCHEMBL24908958 | 0.76 | MAPT (0.38) | FPR1MAPTNPSR1TP53MEN1 | |
| SCHEMBL24704709 | 0.76 | DNMT1 (0.30) | — | |
| SCHEMBL24908987 | 0.75 | MAPT (0.55) | MAPTNPSR1TP53MEN1KMT2A | |
| SCHEMBL24908968 | 0.75 | RAF1 (0.39) | MAPTSMN1; SMN2NPSR1BRAFALDH1A1 | |
| SCHEMBL24909321 | 0.75 | MAPT (0.40) | MAPTSMN1; SMN2NPSR1TP53BRAF | |
| SCHEMBL24909637 | 0.75 | DNMT1 (0.44) | MAPTSMN1; SMN2NPSR1TP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220389014-A1 | COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM MANUFACTURED THEREFROM, BACKLIGHT UNIT, AND DISPLAY DEVICE | LG CHEM, LTD. (KR) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389014-A1 | COMPOUND, PHOTOSENSITIVE FLUORESCENT RESIN COMPOSITION COMPRISING SAME, COLOR CONVERSION FILM MANUFACTURED THEREFROM, BACKLIGHT UNIT, AND DISPLAY DEVICE | NOTUM, THEM6, FAR1 | FPR1 192/4885MAPT 329/4885SMN1; SMN2 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.